control group:Conventional glucose-lowering therapy other than GLP-1 receptor agonists (semaglutide)

Alterations in ventricular remodeling after application of semaglutide in patients with acute myocardial infarction (AMI) combined with type 2 diabetes mellitus (T2DM) during the perioperative period of emergency percutaneous coronary intervention

Withdraw due to duplicate registration; effect of semaglutide on early cardiac remodeling in diabetic patients after acute myocardial infarction and emergency revascularization: SECR-DAMI study